Tumor tissue CA125 in ovarian carcinoma patients with normal serum levels

被引:4
|
作者
Menczer, J
Zakut, H
Schejter, E
Ginath, S
Tell, L
Zajdel, L
机构
[1] EDITH WOLFSON MED CTR,DEPT PATHOL,IL-58100 HOLON,ISRAEL
[2] TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL
关键词
ovarian carcinoma; serum CA125; tissue CA125;
D O I
10.1046/j.1525-1438.1997.00459.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A good correlation between elevated serum CA125 and its immunolocalization in ovarian tumor tissue has been reported. This study was undertaken in order to assess the presence of CA125 in tumor tissue obtained from ovarian carcinoma patients with normal serum levels. Eleven such ovarian carcinoma patients (nine of them serous) were identified. In seven the level was normal prior to the initial operation, and in four, prior to a positive second-look operation. Immunohistochemical staining of paraffin sections for CA125 was positive in seven of the tumor tissue samples. Tumor tissue of most ovarian carcinoma patients with a preoperative normal serum CA125 contains the antigen, but an undetermined mechanism prevents elevated serum levels.
引用
收藏
页码:304 / 306
页数:3
相关论文
共 50 条
  • [21] Tumor marker CA125 in ovarian cancer
    Tuxen, MK
    JOURNAL OF TUMOR MARKER ONCOLOGY, 2001, 16 (01): : 49 - 68
  • [22] Elevated Preoperative Serum CA125 Predicts Larger Tumor Diameter in Patients with Hepatocellular Carcinoma and Low AFP Levels
    Zhou, Sanshun
    Wang, Zusen
    Li, Manjiang
    Wu, Liqun
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [23] Prevalence of K-RAS mutations and CA125 tumor marker in patients with ovarian carcinoma
    Bagherlou, Nazanin
    Farajnia, Safar
    Zahri, Saber
    Tabrizi, Ali Dastranj
    Nazari, Atefeh
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2020, 11 (01) : 75 - 82
  • [24] CA125 SERUM LEVELS AND SECONDARY LAPAROTOMY IN EPITHELIAL OVARIAN-TUMORS
    ROME, RM
    KOH, H
    FORTUNE, D
    CAUCHI, M
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1987, 27 (02): : 142 - 145
  • [25] CA125 IN OVARIAN TUMOR-TISSUE AT 2ND LAPAROTOMY
    MAUGHAN, TS
    FISH, RG
    SHELLEY, MD
    JASANI, B
    WILLIAMS, GT
    ADAMS, M
    BRITISH JOURNAL OF CANCER, 1989, 59 (02) : 259 - 260
  • [26] MESOTHELIN EXPRESSION AND CA125 SERUM CONCENTRATION IN PATIENTS WITH OVARIAN CANCER
    Barczynski, B.
    Fraszczak, K.
    Tarkowski, R.
    Ziober-Malinowska, P.
    Kulak, K.
    Bobinski, M.
    Polak, G.
    Sobstyl, M.
    Bednarek, W.
    Kotarski, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 635 - 635
  • [27] A STUDY OF SERUM CASA AND CA-125 LEVELS IN PATIENTS WITH OVARIAN-CARCINOMA
    MEISEL, M
    STRAUBE, W
    WEISE, J
    BURKHARDT, B
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1995, 256 (01) : 9 - 15
  • [28] Detection of tumor marker CA125 in ovarian carcinoma using quantum dots
    Wang, HZ
    Wang, HY
    Liang, RQ
    Ruan, KC
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2004, 36 (10) : 681 - 686
  • [29] USE OF CA125 TO PREDICT SURVIVAL OF PATIENTS WITH OVARIAN-CARCINOMA
    RUSTIN, GJS
    GENNINGS, JN
    NELSTROP, AE
    COVARRUBIAS, H
    LAMBERT, HE
    BAGSHAWE, KD
    BRITISH JOURNAL OF CANCER, 1989, 60 (03) : 452 - 452
  • [30] CA125 AND PLACENTAL ALKALINE-PHOSPHATASE AS SERUM TUMOR-MARKERS IN EPITHELIAL OVARIAN-CARCINOMA
    VERGOTE, IB
    ABELER, VM
    BORMER, OP
    STIGBRAND, T
    TROPE, C
    NUSTAD, K
    TUMOR BIOLOGY, 1992, 13 (03) : 168 - 174